Skip to main content
. 2016 Nov 2;146(12):2476–2490. doi: 10.3945/jn.116.238931

TABLE 6.

Hepatic gene expression pathways (genes ranked highest to lowest by percentage difference) affected in male mice fed a 45%-fat diet with or without HAMRS2 supplementation for 10 wk1

Mean, FPKMs
Pathway2 Definition Control HAMRS2 Percentage difference (HAMRS2 relative to control)3
Metabolism of xenobiotics by cytochrome P450 (KEGG pathway: 00980) (C = 77; O = 3; E = 0.08; R = 35.78; rawP = 8.50 × 10−5; adjP = 0.0003)
 Cyp2b9 Cytochrome P450, family 2, subfamily b, polypeptide 9 3.2 9.6 204
 Cyp2c37 Cytochrome P450, family 2, subfamily c, polypeptide 37 66.0 93.9 42
 Cyp2c54 Cytochrome P450, family 2, subfamily c, polypeptide 54 103 133 29
Jak-STAT signaling pathway (KEGG pathway: 04630) (C = 153; O = 5; E = 0.17; R = 30.01; rawP = 7.52 × 10−7; adjP = 1.35 × 10−5)
 Spry4 Sprouty homolog 4 (Drosophila) 2.2 2.9 32
 Il6ra IL-6 receptor, α 9.7 7.4 −24
 Crebbp CREB binding protein 3.9 2.9 −27
 Cish Cytokine inducible SH2-containing protein 16.8 9.9 −41
 Myc Myelocytomatosis oncogene 4.4 2.2 −50
TGF-β signaling pathway (KEGG pathway: 04350) (C = 85; O = 4; E = 0.09; R = 43.22; rawP = 2.42 × 10−6; adjP = 1.37 × 10−5)
 Rock1 Rho-associated coiled-coil containing protein kinase 1 12.5 9.5 −24
 Crebbp CREB binding protein 3.9 2.9 −27
 Inhba Inhibin β-A 2.4 1.5 −39
 Myc Myelocytomatosis oncogene 4.4 2.2 −50
Wnt signaling pathway (KEGG pathway: 04310) (C = 154; O = 3; E = 0.17; R = 17.89; rawP = 0.0007; adjP = 0.0014)
 Rock1 Rho-associated coiled-coil containing protein kinase 1 12.5 9.5 −24
 Crebbp CREB binding protein 3.9 2.9 −27
 Myc Myelocytomatosis oncogene 4.4 2.2 −50
Vascular smooth muscle contraction (KEGG pathway: 04270) (C = 123; O = 3; E = 0.13; R = 22.40; rawP = 0.0003; adjP = 0.0007)
 Cyp4a10 Cytochrome P450, family 4, subfamily a, polypeptide 10 189 245 30
 Rock1 Rho-associated coiled-coil containing protein kinase 1 12.5 9.5 −24
 Ppp1r12a Protein phosphatase 1, regulatory (inhibitor) subunit 12A 5.7 4.1 −27
Arachidonic acid metabolism (KEGG pathway: 00590) (C = 90; O = 4; E = 0.10; R = 40.82; rawP = 3.04 × 10−6; adjP = 1.37 × 10−5)
 Cyp2b9 Cytochrome P450, family 2, subfamily b, polypeptide 9 3.2 9.6 204
 Cyp2c37 Cytochrome P450, family 2. subfamily c, polypeptide 37 66.0 93.9 42
 Cyp4a10 Cytochrome P450, family 4, subfamily a, polypeptide 10 189 245 30
 Cyp2c54 Cytochrome P450, family 2, subfamily c, polypeptide 54 103 133 29
Retinol metabolism (KEGG pathway: 00830) (C = 77; O = 4; E = 0.08; R = 47.71; rawP = 1.63 × 10−6; adjP = 1.37 × 10−5)
 Cyp2b9 Cytochrome P450, family 2, subfamily b, polypeptide 9 3.2 9.6 204
 Cyp2c37 Cytochrome P450, family 2. subfamily c, polypeptide 37 66.0 93.9 42
 Cyp4a10 Cytochrome P450, family 4, subfamily a, polypeptide 10 189 245 30
 Cyp2c54 Cytochrome P450, family 2, subfamily c, polypeptide 54 103 133 29
Biosynthesis of unsaturated FAs (KEGG pathway: 01040) (C = 25; O = 2; E = 0.03; R = 73.47; rawP = 0.0003; adjP = 0.0007)
 Acot3 Acyl-CoA thioesterase 3 9.0 13.2 47
 Elovl6 ELOVL family member 6, elongation of long-chain FAs (yeast) 15.5 12.1 −22
Linoleic acid metabolism (KEGG pathway: 00591) (C = 46; O = 2; E = 0.05; R = 39.93; rawP = 0.0012; adjP = 0.0022)
 Cyp2c37 Cytochrome P450, family 2. subfamily c, polypeptide 37 66.0 93.9 42
 Cyp2c54 Cytochrome P450, family 2, subfamily c, polypeptide 54 103 133 29
1

Pathways are derived from liver transcriptomics data. Parameters—organism: mus musculus; ID type: gene_symbol; reference set: mmusculus_genome; statistic: hypergeometric; significance level: Top10; multiple test correction: Benjamini-Hochberg; minimum number of genes for a category: 2. Genes included have an adjusted P value ≤ 0.05. adjP, P value adjusted by the multiple test adjustment; FPKM, fragment per kilobase of transcript per million; HAMRS2, high-amylose-maize resistant starch type 2; KEGG, Kyoto Encyclopedia of Genes and Genomes; rawP, P value from hypergeometric test.

2

The C, O, E, and R in parentheses indicate the number of reference genes in the category, number of genes in the gene set and also in the category, the expected number in the category, and the ratio of enrichment, respectively.

3

Percentage difference = [(HAMRS2 − control)/control] × 100.